e7 tcr-t cells
HPV-Related Adenosquamous Carcinoma
Christian HinrichsCell therapyPhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 81/ 100
Competitive context
7 Active assets in the HPV-Related Adenosquamous Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin Pfizer | Phase 3 | B |
cp-751,871 Pfizer | Phase 3 | CCC |
Tsc-202-A0201 TScan Therapeutics, Inc. | Phase 1 | CC |
Tsc-204-A0101 TScan Therapeutics, Inc. | Phase 1 | CC |
Tsc-201-B0702 TScan Therapeutics, Inc. | Phase 1 | CC |
View all 9 →
Same molecule, other indications
e7 tcr-t cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →